FCGR2A and FCGR3A polymorphisms and response to rituximab treatment in patients with B-cell chronic lymphocytic leukemia.

Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/23835

DC Field	Value	Language
dc.contributor.author	Angelovic R	en_US
dc.contributor.author	Pavkovic M	en_US
dc.contributor.author	Panovska Stavridis I	en_US
dc.contributor.author	Arangelovic E	en_US
dc.contributor.author	Trajkova S	en_US
dc.contributor.author	Cadievski L	en_US
dc.contributor.author	Stojanovic A	en_US
dc.date.accessioned	2022-10-27T07:17:51Z	-
dc.date.available	2022-10-27T07:17:51Z	-
dc.date.issued	2019	-
dc.identifier.uri	http://hdl.handle.net/20.500.12188/23835	-
dc.language.iso	en	en_US
dc.title	FCGR2A and FCGR3A polymorphisms and response to rituximab treatment in patients with B-cell chronic lymphocytic leukemia.	en_US
dc.type	Proceeding article	en_US
dc.relation.conference	13th Balkan Congress of Human Genetics. Edirne, Turkey, 2019, P-067.	en_US
item.grantfulltext	open	-
item.fulltext	With Fulltext	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
Appears in Collections:	Faculty of Medicine: Conference papers